Efficacy and safety of rituximab in patients with multiple sclerosis: An observational study at a tertiary center in Makkah, Saudi Arabia.
Neurosciences (Riyadh). 2022 Apr;27(2):65-70. doi: 10.17712/nsj.2022.2.20210122.
Neurosciences (Riyadh). 2022.
PMID: 35477910